<SEC-DOCUMENT>0001213900-19-025155-index.html : 20191202
<SEC-HEADER>0001213900-19-025155.hdr.sgml : 20191202
<ACCEPTANCE-DATETIME>20191202172943
ACCESSION NUMBER:		0001213900-19-025155
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20191125
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20191202
DATE AS OF CHANGE:		20191202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AdvanSource Biomaterials Corp
		CENTRAL INDEX KEY:			0001011060
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043186647
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11737
		FILM NUMBER:		191264068

	BUSINESS ADDRESS:	
		STREET 1:		229 ANDOVER STREET
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887
		BUSINESS PHONE:		978-657-0075

	MAIL ADDRESS:	
		STREET 1:		229 ANDOVER STREET
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDIOTECH INTERNATIONAL INC
		DATE OF NAME CHANGE:	19960321
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k1219_advansourcebio.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k1219_advansourcebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>f8k1219ex2-1_advansource.htm
<DESCRIPTION>ASSET PURCHASE AGREEMENT
<TEXT>
Document 2 - file: f8k1219ex2-1_advansource.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>f8k1219ex10-1_advansource.htm
<DESCRIPTION>VOTING AND SUPPORT AGREEMENT
<TEXT>
Document 3 - file: f8k1219ex10-1_advansource.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>exb_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: exb_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>exb_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: exb_002.jpg

</DOCUMENT>
</SEC-DOCUMENT>